GNH USA

Europe — EMA

Lamivudina + Zidovudina Aurobindo

GNH USA supplies Lamivudina + Zidovudina (Lamivudine/Zidovudine), a nucleoside reverse transcriptase inhibitor for HIV infection and AIDS.

Zidovudine, Lamivudine

Request sourcing

1
Pack/s

What is Zidovudine, Lamivudine?

Lamivudine and Zidovudine, the active ingredients in Lamivudina + Zidovudina Aurobindo, are nucleoside reverse transcriptase inhibitors presented as tablets for oral use. They treat HIV infection and AIDS in adults and children.

GNH USA supplies Lamivudina + Zidovudina Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Zidovudine, Lamivudine used for?

Lamivudina + Zidovudina is used in antiretroviral therapy targeting HIV replication.

- HIV infection: reduces viral load and slows disease progression - AIDS: helps improve immune function and reduces opportunistic infections - Treatment‑experienced HIV patients: provides an additional NRTI option in combination regimens

What are the side effects of Zidovudine, Lamivudine?

Lamivudina + Zidovudina may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Headache - Fatigue - Anemia - Diarrhea - Insomnia

Serious or Rare Side Effects: - Lactic acidosis - Severe neutropenia - Hepatotoxicity - Hypersensitivity reactions - Pancreatitis - Severe anemia

What precautions apply to Zidovudine, Lamivudine?

When prescribing Lamivudina + Zidovudina, clinicians should consider several safety precautions.

- Renal impairment: adjust dose or monitor renal function - Hepatic disease: monitor liver enzymes regularly - Hematologic disorders: watch for anemia or neutropenia - Pregnancy: use only if benefits outweigh risks, as safety data are limited - Concomitant medications: review for potential drug interactions - Store at ambient temperature: keep below 25°C in original packaging, protect from moisture

What does Zidovudine, Lamivudine interact with?

Lamivudina + Zidovudina can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Didanosine: increased risk of peripheral neuropathy and pancreatitis - Stavudine: heightened mitochondrial toxicity - Rifampicin: reduces plasma concentrations of both agents - Ritonavir or cobicistat: may alter metabolism of the NRTIs - Myelosuppressive agents: additive bone marrow suppression

Moderate Interactions (Monitor Closely): - Non‑nucleoside reverse transcriptase inhibitors (efavirenz, nevirapine): may affect drug levels - Warfarin: monitor INR for anticoagulant effect - Oral contraceptives: possible reduced efficacy, consider alternative contraception - Azole antifungals (ketoconazole): monitor for toxicity - Immunosuppressants (cyclosporine): dose adjustments may be required

Frequently asked questions

What is Lamivudina + Zidovudina used for?+
Lamivudina + Zidovudina is an antiretroviral medication indicated for the treatment of HIV infection and AIDS. It is used as part of combination therapy to suppress viral replication, improve immune function, and reduce the risk of opportunistic infections in both adult and pediatric patients.
How does Lamivudine work in the combination?+
Lamivudine is a nucleoside reverse transcriptase inhibitor that, after intracellular phosphorylation, mimics natural nucleosides and is incorporated into viral DNA by HIV reverse transcriptase. This incorporation halts DNA chain elongation, leading to premature termination of viral replication.
What determines the usual dose of Lamivudina + Zidovudina?+
The dosage of Lamivudina + Zidovudina is individualized by the prescribing clinician based on factors such as the patient’s age, weight, renal and hepatic function, and the overall antiretroviral regimen. No fixed dose can be stated without a medical prescription.
Is Lamivudina + Zidovudina safe during pregnancy or breastfeeding?+
Safety data for Lamivudina + Zidovudina in pregnancy and lactation are limited. The medication should be used only if the potential benefits to the mother outweigh any possible risks to the fetus or infant, and the decision should be made in consultation with a healthcare professional.
How do I order Lamivudina + Zidovudina from GNH USA?+
To order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does this combination compare with other antiretroviral options?+
Lamivudina + Zidovudine offers a dual‑NRTI backbone that is well‑studied, generally well‑tolerated, and compatible with many other antiretroviral classes. Compared with newer agents, it may have a more established safety profile but can be associated with mitochondrial toxicity, requiring monitoring for lactic acidosis and peripheral neuropathy.
What are the recommended storage conditions for Lamivudina + Zidovudina?+
Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original container, protect from moisture and direct sunlight, and ensure the packaging remains sealed until use.
How is Lamivudina + Zidovudina administered?+
The medication is taken orally, usually with or without food, as directed by the prescribing clinician. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed by a healthcare professional.
What are the most serious risks to watch for while taking Lamivudina + Zidovudina?+
Serious adverse events include lactic acidosis, severe neutropenia, hepatotoxicity, hypersensitivity reactions, and pancreatitis. Patients should be educated to seek immediate medical attention if they experience unexplained abdominal pain, rapid breathing, severe fatigue, or signs of infection.
Who should not use Lamivudina + Zidovudina?+
Individuals with known hypersensitivity to lamivudine, zidovudine, or any excipients in the formulation should avoid the product. Caution is also advised for patients with severe hepatic or bone‑marrow impairment, as the drug may exacerbate these conditions.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Zidovudine, Lamivudine
Route
Oral Use
Manufacturer
Generis Farmacêutica, S.A.
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU